Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication

Human coronavirus (HCoV) similar to other viruses rely on host cell machinery for both replication and to spread. The p97/VCP ATPase is associated with diverse pathways that may favor HCoV replication. In this study, we assessed the role of p97 and associated host responses in human lung cell line H...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kai-Wen Cheng, Shan Li, Feng Wang, Nallely M. Ruiz-Lopez, Nadia Houerbi, Tsui-Fen Chou
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
p97
Acceso en línea:https://doaj.org/article/40fe4a94fc7f42a7b79bd4b240b002e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:40fe4a94fc7f42a7b79bd4b240b002e6
record_format dspace
spelling oai:doaj.org-article:40fe4a94fc7f42a7b79bd4b240b002e62021-11-25T17:09:45ZImpacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication10.3390/cells101129532073-4409https://doaj.org/article/40fe4a94fc7f42a7b79bd4b240b002e62021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2953https://doaj.org/toc/2073-4409Human coronavirus (HCoV) similar to other viruses rely on host cell machinery for both replication and to spread. The p97/VCP ATPase is associated with diverse pathways that may favor HCoV replication. In this study, we assessed the role of p97 and associated host responses in human lung cell line H1299 after HCoV-229E or HCoV-OC43 infection. Inhibition of p97 function by small molecule inhibitors shows antiviral activity, particularly at early stages of the virus life cycle, during virus uncoating and viral RNA replication. Importantly, p97 activity inhibition protects human cells against HCoV-induced cytopathic effects. The p97 knockdown also inhibits viral production in infected cells. Unbiased quantitative proteomics analyses reveal that HCoV-OC43 infection resulted in proteome changes enriched in cellular senescence and DNA repair during virus replication. Further analysis of protein changes between infected cells with control and p97 shRNA identifies cell cycle pathways for both HCoV-229E and HCoV-OC43 infection. Together, our data indicate a role for the essential host protein p97 in supporting HCoV replication, suggesting that p97 is a therapeutic target to treat HCoV infection.Kai-Wen ChengShan LiFeng WangNallely M. Ruiz-LopezNadia HouerbiTsui-Fen ChouMDPI AGarticlecoronavirusp97ATPaseproteomicsinhibitorBiology (General)QH301-705.5ENCells, Vol 10, Iss 2953, p 2953 (2021)
institution DOAJ
collection DOAJ
language EN
topic coronavirus
p97
ATPase
proteomics
inhibitor
Biology (General)
QH301-705.5
spellingShingle coronavirus
p97
ATPase
proteomics
inhibitor
Biology (General)
QH301-705.5
Kai-Wen Cheng
Shan Li
Feng Wang
Nallely M. Ruiz-Lopez
Nadia Houerbi
Tsui-Fen Chou
Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication
description Human coronavirus (HCoV) similar to other viruses rely on host cell machinery for both replication and to spread. The p97/VCP ATPase is associated with diverse pathways that may favor HCoV replication. In this study, we assessed the role of p97 and associated host responses in human lung cell line H1299 after HCoV-229E or HCoV-OC43 infection. Inhibition of p97 function by small molecule inhibitors shows antiviral activity, particularly at early stages of the virus life cycle, during virus uncoating and viral RNA replication. Importantly, p97 activity inhibition protects human cells against HCoV-induced cytopathic effects. The p97 knockdown also inhibits viral production in infected cells. Unbiased quantitative proteomics analyses reveal that HCoV-OC43 infection resulted in proteome changes enriched in cellular senescence and DNA repair during virus replication. Further analysis of protein changes between infected cells with control and p97 shRNA identifies cell cycle pathways for both HCoV-229E and HCoV-OC43 infection. Together, our data indicate a role for the essential host protein p97 in supporting HCoV replication, suggesting that p97 is a therapeutic target to treat HCoV infection.
format article
author Kai-Wen Cheng
Shan Li
Feng Wang
Nallely M. Ruiz-Lopez
Nadia Houerbi
Tsui-Fen Chou
author_facet Kai-Wen Cheng
Shan Li
Feng Wang
Nallely M. Ruiz-Lopez
Nadia Houerbi
Tsui-Fen Chou
author_sort Kai-Wen Cheng
title Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication
title_short Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication
title_full Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication
title_fullStr Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication
title_full_unstemmed Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication
title_sort impacts of p97 on proteome changes in human cells during coronaviral replication
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/40fe4a94fc7f42a7b79bd4b240b002e6
work_keys_str_mv AT kaiwencheng impactsofp97onproteomechangesinhumancellsduringcoronaviralreplication
AT shanli impactsofp97onproteomechangesinhumancellsduringcoronaviralreplication
AT fengwang impactsofp97onproteomechangesinhumancellsduringcoronaviralreplication
AT nallelymruizlopez impactsofp97onproteomechangesinhumancellsduringcoronaviralreplication
AT nadiahouerbi impactsofp97onproteomechangesinhumancellsduringcoronaviralreplication
AT tsuifenchou impactsofp97onproteomechangesinhumancellsduringcoronaviralreplication
_version_ 1718412643309453312